Mübeccel Akdis MD, PhD
Dr Mubeccel Akdis-SIAF. Dr Akdis graduated in Medical faculty from Uludag University, Bursa in 1985. She was employed by the Swiss Institute of Allergy and Asthma Research in 1995 and received her PhD in Immunology. Thereafter, Dr Akdis was employed as a postdoctoral scientist at which time she became a group leader at SIAF, where she has established her own research group since 2003. Dr Akdis made her habilitation (Venia Legendi) in Zurich University Medical Faculty on Experimental Immunology in 2005. She has published 167 peer-reviewed research articles (total citations 10912; average citations; 65.3; h index 57, First and last author articles cited more than 100 times: 33). In addition, she has research grants and collaborative grants from the Swiss National Foundation and European Union (WP leader of 2 European projects). She received numerous awards, including Ferdinand Wortman Prize, Professor Hans Storck Award, Sedat Simavi Medicine Award. Dr Akdis is the editorial board member of Allergy and Journal of Allergy and Clinical Immunology.
Her research has been focused on strategies for efficient prevention and curative treatment of allergic diseases and has exploited recent developments for the identification of ways for the cure of allergic diseases. Extensive progress has been made in the understanding of the mechanisms of allergic diseases within the complex interaction of effector T cells, other effector cells, resident tissue cells and different subsets of Treg cells. Currently, her research group has developed essential techniques and a specific niche to investigate human allergen-specific effector and regulatory B cells through the several recent studies that the group has published. In her research, human in vivo systems are continuously being investigated to better understand the cellular and molecular mechanisms of disease development for better prevention and treatment.